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EFFICACY OF SMART INFUSION PUMPS
Abstract
In today’s healthcare, intravenous (IV) therapy-related errors have become rampant and
are responsible for a substantial portion of hospital injuries and deaths. In the last decade,
however, since the development and implementation of “smart” IV pumps, a significant
number of these IV medication errors have allegedly been reduced. The purpose of this
paper is to discuss research surrounding an evaluation of the efficacy of smart IV pumps
from a nursing perspective.
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EFFICACY OF SMART INFUSION PUMPS
Efficacy of Smart Infusion Pumps from a Nursing Perspective
Chapter 1: Introduction
Introduction.
According to the U.S. Food & Drug Administration (2016), medication errors are
responsible for at least one death every day and injure an astonishing 1.5 million people
annually in the United States alone. Since IV medications, when compared with
medications delivered via other routes, lead to higher systemic bodily concentrations and
produce more rapid, potentially irreversible side effects, they are twice as likely to cause
patient harm (Reston, 2013). Interestingly, Dulak (2005) estimates that, on average, 90%
of hospitalized patients receive IV therapy in some capacity. Even though a medication
mishap can occur anywhere in the prescribing, packaging, dispensing, administering, or
monitoring processes, studies have indicated a larger than normal error rate (73%) in the
actual administration process. The development of the smart IV pump, however, when
used according to its design, has become a necessary component of a comprehensive and
safe medication system, one that has successfully combatted error-related issues in this
administration process. According to a recent survey, nearly 80% of hospitals in the
United States currently utilize IV smart pump technology (Association for the
Advancement of Medical Instrumentation [AAMI], 2016).
Background of the Problem.
The first programmable and very basic IV infusion pumps were developed more
than 40 years ago (Proctor, 2014). Although these pumps were regarded as quite
innovative at the time, they allowed the caregiver to input only limited information, such
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as the medication’s volume-to-be-infused (VTBI) and the infusion rate. Lacking in
technological sophistication, these pumps were risky in that they allowed for a wide
range of medication programming with no alerts or alarms. For instance, all medications
or blood products, even those considered high-alert or high-risk such as insulin, opiates,
anti-coagulants, and sedatives could be infused at various rates starting as low as 0.1
milliliters (mL) per hour to as high as 999 mL or more per hour. Over the years, these
shortcomings have led to patients receiving lethal doses of medications. According to the
U.S. Food & Drug Administration (2016), there were 56,000 reports of infusion-related
incidents, including 710 deaths, resulting in the recall of 87 infusion pumps in the United
States.
It wasn’t until the late 1990s that smart IV pumps became the catalyst for change.
A technological breakthrough, electronically erasable programmable read-only memory
(EEPROM), made it possible for infusion pumps to contain safety software that could be
customized to a hospital’s specific care area and tailored to meet individual patient needs
(Proctor, 2014). Dose error-reduction systems (DERS) embedded within smart pumps
have drastically improved the safety of IV infusion therapies. Unlike the former infusion
pumps, predetermined drug libraries now produce an alert if pump programming exceeds
hospital-established limits. Most smart pump software provides soft alerts, or soft stops,
as well as hard alerts, or hard stops. Soft stops prompt users to reconsider a given drug
dosage but have limitations in that they purely serve as a reminder and can be overridden;
hard stops, however, abruptly prevent users from proceeding beyond the stated dose
limits (Reston, 2013). Hard stops have proven to be more effective since they do not
allow easy circumvention; smart pumps also log alerts including the time, date, drug,
2
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concentration, programmed rate, and volume to be infused, allowing for valuable
continuous quality improvement (CQI) data (Dulak, 2005). Most smart pump programs
continuously display the name of the medication being infused, the dose, the rate, and the
volume left to be infused, as well.
It is evident that smart pumps now have the capability to prevent errors related to
incorrect programming, but it is important to note that infusion-related errors can still
occur if the wrong medication is given to the right patient, even if the pump is
programmed correctly for the given medication. When a barcode medication
administration system is integrated with a smart pump, however, the Five Rights of
Medication Administration, which entails giving the right dose of the right medication to
the right patient via the right route at the right time, becomes increasingly more accurate
(Dulak, 2005). The numerous benefits of smart infusion technologies are clear, but it is
important to understand that a smart pump’s efficacy is dependent on its user. Poor
caregiver compliance with the drug library and dosage limits can drastically limit the
advantages of smart pump decision support. Due to poor implementation and
communication processes, one study conducted at an independent community hospital in
Massachusetts found that the nursing staff utilized the smart pump library with only 37%
of all infusions (Harding, n.d.). Some nurses felt that pump programming was frequently
rushed or omitted altogether due to time constraints and competing work demands. In
2005, another study that involved 735 cardiac surgery patients resulted in 14 adverse
events. Perhaps these outcomes could have been prevented had the nursing staff not
bypassed the drug library, an occurrence that happened 25% of the time (Reston, 2013).
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Purpose of Study.
Thus, the purpose of this study is to gauge the extent of which obstetrical nurses
at five East Tennessee hospitals perceive smart IV infusion pumps as helpful in
improving patient safety by reducing harm. This research also aims to evaluate the
prevalence of the proper use of smart IV pumps by the nursing staff. This study also
gathers participant demographic information to assess for trends.
Significance of Study.
Medication errors associated with IV pumps are historically proven to occur
frequently, have the potential to cause harm, and are epidemiologically diverse (Husch,
Sullivan, Rooney, Barnard, Fotis, Clarke, & Noskin, 2005). Proctor (2014), however,
emphasizes the following benefits since the widespread implementation of smart IV
pumps: fostered development of drug dose limits, standardization of concentration and
dosing units, allowance of hospitals to configure pumps to match applications, provision
of a plethora of infusion data, documentation of “good catches” from prevented
programming errors, promotion of wireless connectivity/server applications, and
identification of human factors and opportunities for manufacturer improvements. Since
smart IV pumps demonstrate these numerous potential benefits to the already risky
medication administration process, it is important to assess and encourage the proper use
by the nurses who directly interact with them. Moreover, patients deserve the safest
medical care and with the evolution of technological advancements, such as said smart IV
pumps, desirable clinical outcomes have become even easier to attain.
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Research Questions.
This anonymously-reported study contains three basic demographic questions
followed by four smart IV pump-related statements in which the nurse is asked to rank
his/her agreement, disagreement, or indifference accordingly. The last question provides
an optional free-text comment box. The questions/statements and available responses are
as follows:
1. How long have you practiced BEDSIDE nursing?
o <1 year
o 1-3 years
o 4-10 years
o 11-20 years
o >20 years
2. What shift do you primarily work?
o Dayshift
o Nightshift
o PRN
o Varies/No Set Shift
3. What is your age?
o 22-30 Years Old
o 31-40 Years Old
o 41-50 Years Old
o 51-60 Years Old
o >60 Years Old
5
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4. Smart IV pumps improve patient safety by reducing harm associated with
medication errors.
o Strongly Agree
o Agree
o Indifferent/Unsure
o Disagree
o Strongly Disagree
5. The presence of embedded alerts, alarms, and/or functionalities that deny
overriding have prevented the following IV-related error(s) in my clinical past
(select all that apply):
o Blood/Blood Product(s)
o Medication(s)
o IV Fluid(s)
o None
o Unsure
6. Learning to operate smart IV pumps is easy and user-friendly.
o Strongly Agree
o Agree
o Indifferent/Unsure
o Disagree
o Strongly Disagree
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7. Smart IV pumps’ eventual integration with the eMAR, CPOE, and barcode
scanning systems will further improve patient safety (i.e. scanning the patient’s
armband + scanning the IV infusion(s) = automatic pump programming).
o Strongly Agree
o Agree
o Indifferent/Unsure
o Disagree
o Strongly Disagree
8. Comments?
Definition of Terms.
For clarification purposes, the following is a list of terms used within this research
project and their meanings:
1. Anti-coagulants – a drug that acts to prevent blood clots by thinning the blood.
2. Barcode medication administration system – the use of an electronic device,
specifically a barcode scanner, that can read/scan the barcode on a patient’s
hospital armband and on medication labels to aid in medication error
prevention.
3. Cardiac – of, or relating to, the human heart.
4. Computerized provider order entry (CPOE) – an electronic means for a
licensed healthcare provider to input patient care orders.
5. Electronic medication administration record (eMAR) – an electronic report
that serves as a legal record of drugs administered to a patient.
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6. Infusion rate – the rate, usually measured as mL/minute or mL/hour, at which
an IV-related therapy is administered to achieve therapeutic effectiveness.
7. Insulin – a hormone that can be administrated via the IV or subcutaneous (SQ)
route to decrease blood glucose levels.
8. Intravenous – associated with, or administered into, a vein or veins.
9. Opiates – a drug with Morphine-like effects, derived from opium.
10. Sedatives – a drug that acts to induce sleep and/or promote calmness.
11. Volume-to-be-infused (VTBI) – the total amount, usually measured in mL,
that a patient is to receive of a provider-ordered IV therapy.
Limitations.
This study is limited in that it will only be conducted and representative of one
nursing specialty within five hospitals in the United States. Additionally, due to its
localized distribution within East Tennessee facilities only, the survey is not
geographically demonstrative of the entire nation. Additionally, Since the
questionnaire/survey will be distributed via e-mail, it is highly unlikely that there will be
a 100% response rate, especially with email recipients who don’t periodically check their
email inbox or work often. This study is also limited in that it pertains to registered
nurses practicing in an inpatient setting only, thus excluding ambulatory scenarios.
Chapter 2: Review of Literature
Method.
The purpose of this excerpt is to review the literature surrounding smart IV pumps
to determine its efficacy, or lack thereof. Electronic articles for this literature review
surrounding IV smart pumps were retrieved from the PubMed database. The search was
8
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confined to the human species with publication dates between the years of 2005 to the
present. Articles in the English language only were of interest. The search was further
limited to the following free full-text articles: clinical trials, journal articles, metaanalyses, reviews, and systematic reviews. The following search terms were employed:
“IV smart pump” OR “IV smart pumps” OR “smart IV pump” OR “smart IV pumps” OR
“smart pump” OR “smart pumps” OR “smart infusion technology” OR “smart infusion
pump” OR “smart infusion pumps”. This very specific search yielded a total of 13
articles. Of those, only 3 articles, which I will further discuss in this paper, contained data
and pertinent information for the purposes of this research.
Populations Studied.
The first study took place at Brigham and Women’s Hospital (BWH), a 793-bed
tertiary care academic medical center in Boston, Massachusetts. Data was collected from
55 inpatients from three different clinical areas: one medical intensive care unit (ICU),
one surgical ICU, and one general surgical unit. The second study focused on a patient
population from the ICU setting where 4,604 critically ill adults from one academic and
one non-academic medical center were under scrutiny. This study examined 20,000 beddays of care in surgical, trauma/burn, and medical ICUs (Nuckols et al., 2008). The third
case was conducted at a 500-bed women and pediatrics specialty hospital.
Survey Method.
The literature revealed various methods for conducting research within each of
the three studies. The first journal article used a prospective point prevalence approach.
Designated observation nurses were responsible for comparing, at the bedside, the
9
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medication, dose, and rate on the smart pump against the prescriber’s orders in the
medical record. To confirm that an error was present, two observers had to be in
agreement. An observational tool was developed to collect all IV medication error data.
This particular tool was developed using the REDCap application, a Health Insurance
Portability and Accountability Act (HIPAA)-compliant, web-based application that can
be accessed via personal computers and/or cell phones (Nuckols et al., 2008). Figure 2
below provides a screenshot of the REDCap tool:

Figure 2. Screen shot of the data collection tool (REDCap). Copied from “Evaluation of
Intravenous Medication Errors with Smart Infusion Pumps in an Academic Medical
Center,” by Ohashi et al., 2013, AMIA Annual Symposium Proceedings, 2013, 1089–
1098. Copyright 2013 by AMIA. Copied with permission.
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By using a retrospective medical record review, the second study examined
preventable IV-related adverse drug events (ADEs) in ICUs before and after both
hospitals replaced conventional pumps with smart pumps (Nuckols, 2008). Both
quantitative and qualitative methods were used. The third journal article conducted
research as a retrospective pre-post study.
Findings.
According to the first study conducted by Ohashi et al. (2013), 181 medications
were observed during the data period. Of these observations, a whopping 171 (94.5%)
had one or more errors associated with their administration, with the largest percentage
representing a violation of hospital policy regarding labeling of medications and IV
tubing. Regarding actual smart pump handling errors, however, observers found only four
incidences. The first two cases involved two clamped medication IV bags, which were
supposed to be unclamped/open; the latter two pump errors consisted of one with an
incorrect rate and the other with an incorrect medication altogether (Ohashi et al., 2013).
Based on these findings, the likelihood of error preventability with smart pump
technologies was assessed. Since the first two cases involving the clamped medication
bags were intercepted and communicated to the nurses prior to the medication reaching
the patient, and since smart pumps at the time of this study couldn’t detect secondary IV
bag flows, it’s impossible to theoretically predict whether an error would have occurred
(Ohashi et al., 2013). In error cases 3 and 4, both were human programming errors in
which the nurse chose an incorrect IV fluid, in this instance normal saline instead of ½
normal saline and programmed an incorrect infusion rate. Fortunately, the mistakes were
11
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non-critical, causing no harm to the patients, but what’s concerning is the smart pumps’
lack of alerts to the nurse that there may be a problem. Moreover, to achieve maximum
patient protection, the article discusses the need for smart pumps to seamlessly integrate
or connect with order entry systems and/or the patient’s eMAR; the study further
comments that only when all medication data including dose, concentration, and rate can
be retrieved from physician orders on electronic records in real-time can typing and
selecting errors be eliminated (Ohashi et al., 2013). Based on these findings, the four
errors were rated unlikely to be prevented by in-use smart pump technology. Table 3
below illustrates these errors and their likelihood to cause harm.

Error NCC
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Likelihood of
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MER

error
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preventabilit

#

P

IV pump

y with smart
pump
technology

1

2

C

C

Clamp

Cefepime

Cefepime

closed

2g/50mL,

2g/50mL,

16.7m/hr

16.7m/hr

(observed at

administered at

9:49am)

9:02am

Clamp
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Error NCC
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wrong(pharmacy
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Table 3. Examples of errors with potential harms. Copied from “Evaluation of
Intravenous Medication Errors with Smart Infusion Pumps in an Academic Medical
Center,” by Ohashi et al., 2013, AMIA Annual Symposium Proceedings, 2013, 1089–
1098. Copyright 2013 by AMIA. Copied with permission.

According to the second study conducted by Nuckols et al. (2008), of the 100
preventable IV-ADEs that were identified, only 4 cases involved errors matching smartpump features, with two of the cases occurring prior to smart pump implementation and
the remaining two cases occurring after smart pump implementation. The majority of
preventable IV-ADEs were attributed to other causes. Overall, 29% of preventable IVADEs involved overdoses, 37% involved failure to monitor for potential problems, and
the remaining 45% occurred due to the caregiver’s failure to intervene when problems
appeared (Nuckols et al., 2008). Thus, this study also concluded that smart pumps were
relatively unlikely to prevent medication errors since they were responsible for only 4%
of the total number of recorded adverse events.
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The hospital in the third study conducted by Guérin et al. (2015) implemented a
total of 1,045 smart pumps. The reported number of adverse IV drug events was
collected before and after the implementation of smart IV pumps. According to
Guérin et al. (2015), a total of 2,911 events were self-reported by clinical staff in the
pre-phase (Y0), 3,523 in the initial post-phase (Y1), and 2,788 in the secondary postphase (Y2). Since the fluctuations essentially negated one another, this study also
concluded that there were no risk reductions associated with the implementation of
smart pumps in the 500-bed mother/child hospital.
Limitations.
All three studies included in this literature review contained limitations. The
first study was limited in that it was a point prevalence study, versus a long-term
observational study. Ohashi et al. (2013) asserts that collected data on a single day is
not always reflective of practices on other days. The sample size was also fairly small
at N=55. Regarding limitations with the second study, the authors conclude that they
may have underestimated events matching smart pump functions due to an inability to
evaluate smart pump logs or observe its users (Nuckols et al., 2008). This study was
also limited in that it didn’t include a non-ICU patient population. Lastly, the third study
was limited due to its potential for inaccuracies from a lack of reporting all incidents.
This is especially true since the events were self-reported and the participants may have
feared repercussions for their mistakes. Additionally, this study was limited due to its
focus on a specific patient population.
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Conclusion.
This literature review concludes that smart pumps, despite some positive
societal hype, have the potential to still cause infusion-related errors. When a barcode
medication administration system, CPOE, and the eMAR are all integrated with a smart
IV pump, however, this likelihood seems to lessen. Some smart infusion pump vendors,
such as Hospira, have accomplished this with the innovation of the Plum 360™ Infusion
System. Using Hospira’s IV Clinical Integration solution, this pump has the remarkable
capability of integrating with the electronic medical record (EMR). By doing so,
programming takes place automatically, populating the Plum 360™ Infusion System with
medication orders sent directly from the pharmacy or the CPOE system (Hospira, 2017).
Patient safety remains at the forefront of this newly designed smart IV pump due to its
wireless integration. With the use of Hospira’s Plum 360™ Infusion System, the chances
of not only programming a pump incorrectly are nearly eliminated, but the chances of
administering the wrong medication to the right patient are decreased. This, of course,
only holds true if the provider prescribes the correct medication, the pharmacist validates
the medication as appropriate for the patient, and the nurse also uses critical thinking and
sound judgment to confirm clinical appropriateness.
As previously mentioned, the supplementary processes of prescribing, dispensing,
and monitoring all play a pivotal role in ensuring that patients receive proper treatments.
Ultimately, this literature review revealed that smart infusion pumps might not
significantly reduce adverse drug events after all. It is believed, however, that with the
expansion of smart pumps’ capabilities and functionalities to integrate with the eMAR, a
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means of creating a closed loop clinical system, clinical facilities might experience the
full benefits of IV smart pumps.
Chapter 3: Methodology
Research Design.
This study will be conducted using a descriptive, cross-sectional research design
method in which data will be collected and analyzed at a specific point in time.
Population and Sample Design.
Research will be conducted on the entire obstetrical registered nursing staff at the
following five Covenant Health-owned facilities in East Tennessee: Methodist Medical
Center in Oak Ridge, TN; Parkwest Medical Center in Knoxville, TN; Fort Sanders
Regional Medical Center in Knoxville, TN; LeConte Medical Center in Sevierville, TN;
and Morristown-Hamblen Healthcare System in Morristown, TN.
Data Collection Procedure/Instrument.
Data will be collected via survey research. Informed consent of the nursing staff
will be obtained followed by a brief, standardized questionnaire with seven closed-ended
questions. The survey, which will be disseminated via the organizations’ email system,
will be constructed and completed using the free online survey tool, SurveyMonkey®.
Recipients will be allotted a week’s time to complete the survey. A reminder email will
be sent out nearing the week end of the survey deadline.

17

EFFICACY OF SMART INFUSION PUMPS
Response Rate.
To increase the response rate, and as previously mentioned above, a follow-up
with the respondents in the form of a reminder email will be distributed. A response rate
of greater than 50 percent is desired.
Profile of Sample.
Only registered nurses who are practicing one-on-one patient care at the bedside
in an inpatient hospital setting will be included in this study. Licensed practical nurses
(LPNs) will be excluded. Nurses in administrative and/or non-clinical positions will also
be excluded from this study.
Research Questions.
The collected data from the surveys will be analyzed using descriptive statistics.
Specifically, the mean, a measure of central tendency, will be used to provide an
arithmetic average of all responses. Most of the obtained data will be compared and
displayed on a bar graph. Data results from the second statement which addresses the
participants’ primary shift, however, will be analyzed and visually displayed using a pie
chart.
Chapter 4: Results
Response Rate of Sample.
As originally intended, the survey was distributed to a total of 187 registered
nurses across the five previously mentioned Covenant Health-owned facilities in East
Tennessee. The breakdown for this, according to facility, is as follows: 33 registered
18
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nurses from Methodist Medical Center in Oak Ridge, TN; 45 registered nurses from
Parkwest Medical Center in Knoxville, TN; 12 registered nurses from LeConte Medical
Center in Sevierville, TN; 72 registered nurses from Fort Sanders Regional Medical
Center in Knoxville, TN; and 25 registered nurses from Morristown-Hamblen Healthcare
System in Morristown, TN. Of the 187 total nurses who received the survey, 72 nurses
completed the survey in its entirety, resulting in a 38.5% response rate.
Profile of Sample.
Nurses who had practiced bedside nursing for 4-10 years had the highest survey
response rate at 31.94%. Conversely, only 2.78% of registered nurses having practiced
bedside nursing for less than one year completed the survey. Respondents who had
practiced bedside nursing for 11-20 years had the same response rate of 22.22% as
respondents with >20 years of nursing experience. Over half of the survey’s respondents
work dayshift hours. Nightshift nurses, however, weren’t far behind with a response rate
of 40.28%. Nurses working PRN or varied shifts had the lowest response rate at 2.78%
and 1.39%, respectively. Nearly 35% of the survey responses were from nurses 22-30
years of age. Nurses >60 years of age had the lowest response rate at 6.94%.
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Research Questions.
Q1
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Q2
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Q3
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Q4
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Q5
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Q6
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Q7
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Chapter 5: Summary, Conclusions, and Recommendations
Summary of Findings.
This research study found that nearly all registered nurses agreed that smart IV
pumps improve patient safety by reducing harm associated with medication errors. Half
of the respondents simply agreed, while 48.61% strongly agreed. Only one respondent
determined indifference/uncertainty. Of the 72 registered nurses who were surveyed, 0%
disagreed or strongly disagreed with smart IV pumps’ abilities to improve patient safety.
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According to the survey, respondents reported multiple instances in which smart
IV pumps had prevented errors in their nursing careers. Of these errors, 56.94% of
respondents stated that smart IV pumps prevented medication errors, 26.39% of
respondents reported prevention of IV fluid errors, 20.83% of respondents reported
prevention of blood/blood product(s)-related errors, 19.44% were unsure if smart IV
pumps had prevented any errors, and the remaining 13.89% reported that smart IV pumps
had not prevented any errors.
A large majority of respondents, 93.0% to be exact, alleged to some degree that
smart IV pumps are easy to operate and user-friendly. Only 5.56% were indifferent or
unsure, while only a single respondent disagreed with this statement. When respondents
were asked if smart pumps’ eventual integration with the eMAR, CPOE, and barcode
scanning systems would further improve patient safety, 50.0% strongly agreed, 40.28%
agreed, 8.33% were indifferent or unsure, a single respondent disagreed, and no
respondents strongly disagreed with this statement.
The last survey question, a free-text comment box, was provided to elicit
supplementary information/opinions. Two commenters supported the use of IV smart
pump technology stating, “I would love if we could just scan to program the pump” and
the other respondent remarked that “the use of smart technology can improve clinical
safety for patients. Alerts, medications, and rate limits can be customized on a unit level
and this level of customization provides a safety net for clinical float staff.” Another
commenter took a different stance as he/she “wants to set my own pump according to
directions and my need.” And lastly, further input was provided from a respondent who
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believes that “better tutorials [are] needed for new hires, as brands and functionality
differ between organizations.”
Conclusions and Recommendations.
This unique study which sought to evaluate the efficacy of smart IV pumps from a
nursing perspective produced survey results that were largely in favor of smart IV pump
technology. This study’s results are extremely useful in that no research, to date, has
assessed the effectiveness/success of smart IV pump technology from the actual user’s
perspective. Demographically speaking, the results diversely represent registered nurses
of different age groups with various experience levels. Having a near equal percentage of
dayshift versus nightshift respondents contributes to the reliability and reality of today’s
nursing workforce. A plethora of nurses reported multiple instances in which smart IV
pumps prevented them from making potentially life-threatening errors. In knowing that
IV medications, when compared with medications delivered via other routes, can produce
more rapid, potentially irreversible side effects, the fact that 56.94% of respondents were
able to prevent said errors with the use of IV smart pumps is substantial.
It is important to note that the nursing staff that completed this survey currently
use smart IV pump technology, but not to its full functionality. Smart IV pumps at the
five facilities have yet to be integrated with the eMAR, CPOE, and barcode scanning
systems. Because of this, a future study might entail distributing the same survey
questions after this integration has occurred for result comparison. Additionally, proper
attention should be called to the fact that >90% of nurses envision this integration as
helpful in improving patient safety. Moreover, based on the number of responses
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indicating that a medical error was prevented with the use of smart IV pumps, whether it
be related to blood/blood products, medications, and/or IV fluids, and in addition to the
nursing staff’s positivity regarding ease of use and technological advancements, this
study concludes that the use of smart IV pump technology is recommended in today’s
healthcare facilities.
The implementation of smart pump technology by health systems and hospitals
generally requires considerable planning, including identification of stakeholders,
evaluation of software capabilities, evaluation of hospital-specific practices, decisions
regarding standard operating systems and procedures, building of comprehensive drug
libraries, and education of staff before the pumps can be deployed (Reston, 2013). In
addition, successful implementation cannot occur without motivated multidisciplinary
teams that include not only physicians, pharmacists, and nurses, but also members of the
information technology and informatics teams. With patient safety as the driving force,
smart infusion pumps, when used appropriately, are becoming an essential technology in
healthcare all around the globe.
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